-+ 0.00%
-+ 0.00%
-+ 0.00%

ALLARITY THERAPEUTICS GRANTED U.S. PATENT FOR STENOPARIB’S CLINICAL DOSING REGIMEN, WITH PROTECTION INTO 2045

Reuters·11/18/2026 12:52:07